KAVISH PATIDAR to Risk Factors
This is a "connection" page, showing publications KAVISH PATIDAR has written about Risk Factors.
Connection Strength
0.916
-
Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone. Hepatology. 2025 Apr 01; 81(4):1256-1268.
Score: 0.083
-
Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis. Hepatol Commun. 2023 12 01; 7(12).
Score: 0.080
-
Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study. Liver Transpl. 2024 03 01; 30(3):244-253.
Score: 0.078
-
Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis. Aliment Pharmacol Ther. 2023 06; 57(12):1397-1406.
Score: 0.076
-
The prognostic impact of acute kidney injury recovery patterns in critically ill patients with cirrhosis. Liver Transpl. 2023 03 01; 29(3):246-258.
Score: 0.076
-
Acute kidney disease is common and associated with poor outcomes in patients with cirrhosis and acute kidney injury. J Hepatol. 2022 07; 77(1):108-115.
Score: 0.071
-
Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury. Liver Int. 2022 01; 42(1):187-198.
Score: 0.069
-
Hospital-Acquired Versus Community-Acquired Acute Kidney Injury in Patients With Cirrhosis: A Prospective Study. Am J Gastroenterol. 2020 09; 115(9):1505-1512.
Score: 0.064
-
Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study. J Hepatol. 2020 11; 73(5):1092-1099.
Score: 0.062
-
Admission plasma uromodulin and the risk of acute kidney injury in hospitalized patients with cirrhosis: a pilot study. Am J Physiol Gastrointest Liver Physiol. 2019 10 01; 317(4):G447-G452.
Score: 0.059
-
Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis. Dig Dis Sci. 2017 05; 62(5):1173-1179.
Score: 0.050
-
Optimization and Protection of Kidney Health in Liver Transplant Recipients: Intra- and Postoperative Approaches. Transplantation. 2025 Jun 01; 109(6):938-944.
Score: 0.021
-
Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosis. Liver Transpl. 2025 Jan 01; 31(1):24-31.
Score: 0.021
-
Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium. Aliment Pharmacol Ther. 2024 Sep; 60(6):778-786.
Score: 0.021
-
Optimization of Kidney Health in Liver Transplant Candidates: Pretransplant Considerations and Modalities. Transplantation. 2024 07 01; 108(7):1542-1550.
Score: 0.020
-
Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis. Am J Gastroenterol. 2024 02 01; 119(2):287-296.
Score: 0.020
-
Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1426-e1437.
Score: 0.017
-
Bleeding After Elective Interventional Endoscopic Procedures in a Large Cohort of Patients With Cirrhosis. Clin Transl Gastroenterol. 2020 12 17; 11(12):e00288.
Score: 0.016
-
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease. Liver Int. 2016 Apr; 36(4):572-9.
Score: 0.012